Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients
Status:
Terminated
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
Etanercept is a novel anti-inflammatory agent currently used in patients with rheumatoid
arthritis. We are examining whether Etanercept is effective in improving the nutritional
status of hemodialysis patients as a consequence of its ability to decrease inflammation.